Biofrontera AG/ DE000A4BGGM7 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 8.37 mill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.21 EUR | -98.70% |
| EPS Diluted: | - EUR | -98.70% |
| Revenues per Share: | 10.61 EUR | 25.30% |
| Book Value per Share: | 6.58 EUR | -1.75% |
| Cash Flow per Share: | -0.63 EUR | -51.09% |
| Dividend per Share: | - EUR | - |
| Total | in mill. | |
| Revenues: | 32.25 EUR | 25.30% |
| Net Income: | -0.37 EUR | -99.16% |
| Operating Cash Flow: | -1.91 EUR | - |
| Cash and Cash Equivalents: | 3.08 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 0.26 | 0.79 |
| P/BV ratio: | 0.42 | 1.28 |
| P/CF Ratio: | -4.39 | -13.43 |
| PEG: | 0.13 | - |
| Earnings Yield: | -7.62% | -2.49% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 8.37 mill. EUR | 25.59 mill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 3.04 mill. | |
Profitability
| Gross Profit Margin: | 80.64% |
| EBIT Margin: | 15.91% |
| Net Profit Margin: | -1.14% |
| Return on Equity: | -1.85% |
| Return on Assets: | -1.20% |
Financial Strength
| Liquidity I / Cash Ratio: | 30.58% |
| Liquidity II / Quick Ratio: | 38.26% |
| Liquidity III / Current Ratio: | 175.92% |
| Debt / Equity Ratio: | 53.81% |
| Dynam. Debt / Equity Ratio: | -564.41% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
